Document Detail


The involvement of glycosaminoglycans in airway disease associated with cystic fibrosis.
MedLine Citation:
PMID:  21516290     Owner:  NLM     Status:  In-Data-Review    
Abstract/OtherAbstract:
Individuals with cystic fibrosis (CF) present with severe airway destruction and extensive bronchiectasis. It has been assumed that these structural airway changes have occurred secondary to infection and inflammation, but recent studies suggest that glycosaminoglycan (GAG) remodelling may be an important independent parallel process. Evidence is accumulating that not only the concentration, but also sulphation of GAGs is markedly increased in CF bronchial cells and tissues. Increased expression of GAGs and, in particular, heparan sulphate, has been linked to a sustained inflammatory response and neutrophil recruitment to the CF airways. This present review discusses the biological role of GAGs in the lung, as well as their involvement in CF respiratory disease, and their potential as therapeutic targets.
Authors:
Emer P Reeves; David A Bergin; Michelle A Murray; Noel G McElvaney
Publication Detail:
Type:  Journal Article     Date:  2011-04-19
Journal Detail:
Title:  TheScientificWorldJournal     Volume:  11     ISSN:  1537-744X     ISO Abbreviation:  ScientificWorldJournal     Publication Date:  2011  
Date Detail:
Created Date:  2011-04-25     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101131163     Medline TA:  ScientificWorldJournal     Country:  England    
Other Details:
Languages:  eng     Pagination:  959-71     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Glioblastoma multiforme stem cells.
Next Document:  Adenosine inhibits the release of arachidonic Acid in activated human peripheral mononuclear cells. ...